Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2008

01.06.2008 | POINTS OF VIEW/FORMULATION

The DSM-V initiative “deconstructing psychosis” in the context of Kraepelin’s concept on nosology

verfasst von: Univ.-Prof. Dr. med. Wolfgang Gaebel, Priv.-Doz. Dr. med. Jürgen Zielasek

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Sonderheft 2/2008

Einloggen, um Zugang zu erhalten

Abstract

The revision process of the international psychiatric classification systems has started and is expected to result in new versions of the International Classification of Disorders (then ICD-11) and the Diagnostic and Statistical Manual (then DSM-V) in approximately 2014 and 2012, respectively. In the process of developing DSM-V, several research conferences jointly sponsored by the American Psychiatric Association, the National Institutes of Health, and the World Health Organization, are currently taking place. We will here focus on the impact that the DSM-V initiative “Deconstructing Psychosis” will have on the future of diagnosing a psychotic state, and how this may be viewed from a European context of Kraepelin’s nosology of psychiatric disorders.
Literatur
1.
Zurück zum Zitat Allardyce J, Gaebel W, Zielasek J, Van Os J (2007) Deconstructing psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr Bull 33:863–867PubMedCrossRef Allardyce J, Gaebel W, Zielasek J, Van Os J (2007) Deconstructing psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr Bull 33:863–867PubMedCrossRef
2.
Zurück zum Zitat Andreasen NC (2007) DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr Bull 33:108–112PubMedCrossRef Andreasen NC (2007) DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr Bull 33:108–112PubMedCrossRef
3.
Zurück zum Zitat Benes FM (2007) Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophr Bull, 33:932–936 Benes FM (2007) Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophr Bull, 33:932–936
4.
Zurück zum Zitat Bentall P (2006) Madness explained. Why we must reject the Kraepelinian paradigm and replace it with a “complaint-orientated” approach to understanding mental illness. Med Hypotheses 66:220–233PubMedCrossRef Bentall P (2006) Madness explained. Why we must reject the Kraepelinian paradigm and replace it with a “complaint-orientated” approach to understanding mental illness. Med Hypotheses 66:220–233PubMedCrossRef
5.
Zurück zum Zitat Brase CL (2002) Mental modularity, metaphors, and the marriage of evolutionary and cognitive sciences. Cogn Process 3–4:3–17 Brase CL (2002) Mental modularity, metaphors, and the marriage of evolutionary and cognitive sciences. Cogn Process 3–4:3–17
6.
Zurück zum Zitat Craddock N, Owen MJ (2005) The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186:364–366PubMedCrossRef Craddock N, Owen MJ (2005) The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186:364–366PubMedCrossRef
7.
Zurück zum Zitat Craddock N, Owen MJ (2007) Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6:20–27 Craddock N, Owen MJ (2007) Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6:20–27
8.
Zurück zum Zitat Duchaine B, Cosmides L, Tooby J (2001) Evolutionary psychology and the brain. Curr Opin Neurobiol 11:225–230PubMedCrossRef Duchaine B, Cosmides L, Tooby J (2001) Evolutionary psychology and the brain. Curr Opin Neurobiol 11:225–230PubMedCrossRef
9.
Zurück zum Zitat Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM (2007) Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr Bull, 33:868–876 Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM (2007) Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr Bull, 33:868–876
11.
Zurück zum Zitat First MB, Pincus HA, Levone JB, Williams JBW, Üstün B, Peele R (2004) Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry 161:946–954PubMedCrossRef First MB, Pincus HA, Levone JB, Williams JBW, Üstün B, Peele R (2004) Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry 161:946–954PubMedCrossRef
12.
Zurück zum Zitat Fodor J (1983) The modularity of mind. MIT Press, Cambridge Fodor J (1983) The modularity of mind. MIT Press, Cambridge
13.
Zurück zum Zitat Freedman R (2007) Neuronal dysfunction and schizophrenia symptoms. Am J Psychiatry 164:385–390PubMedCrossRef Freedman R (2007) Neuronal dysfunction and schizophrenia symptoms. Am J Psychiatry 164:385–390PubMedCrossRef
14.
Zurück zum Zitat Gaebel W, Wölwer W, Zielasek J (2006) From descriptive to functional psychopathology: on the way towards a modular psychiatry. Die Psychiatrie 3:221–232 Gaebel W, Wölwer W, Zielasek J (2006) From descriptive to functional psychopathology: on the way towards a modular psychiatry. Die Psychiatrie 3:221–232
15.
Zurück zum Zitat Ginsburg BE, Werick TM, Escobar JI, Kugelmass S, Treaner JJ, Wendtland L (1996) Molecular genetics of psychopathologies: a search for simple answers to complex problems. Behav Genet 26:325–333PubMedCrossRef Ginsburg BE, Werick TM, Escobar JI, Kugelmass S, Treaner JJ, Wendtland L (1996) Molecular genetics of psychopathologies: a search for simple answers to complex problems. Behav Genet 26:325–333PubMedCrossRef
16.
Zurück zum Zitat Go RC, Perry RT, Wiener H, Bassett SS, Blacker D, Devlin B, Sweet RA (2005) Neuregulin-1 polymorphism in late onset Alzheimer’s disease families with psychoses. Am J Med Genet B Neuropsychiatr Genet 139:28–32 Go RC, Perry RT, Wiener H, Bassett SS, Blacker D, Devlin B, Sweet RA (2005) Neuregulin-1 polymorphism in late onset Alzheimer’s disease families with psychoses. Am J Med Genet B Neuropsychiatr Genet 139:28–32
17.
Zurück zum Zitat Gur RE, Keshavan MS and Lawrie SM (2007) Deconstructing psychosis with human brain imaging. Schizophr Bull, 33:921–931 Gur RE, Keshavan MS and Lawrie SM (2007) Deconstructing psychosis with human brain imaging. Schizophr Bull, 33:921–931
18.
Zurück zum Zitat Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT, Rock D, Vile D, Williams R, Corder EH, Hollingsworth K, Jablensky A (2005) Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet 77:468–476PubMedCrossRef Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT, Rock D, Vile D, Williams R, Corder EH, Hollingsworth K, Jablensky A (2005) Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet 77:468–476PubMedCrossRef
19.
Zurück zum Zitat Hoff P (1988) Nosologische Grundpostulate bei Kraepelin. Z Klin Psychol Psychopathol Psychother 36:328–336PubMed Hoff P (1988) Nosologische Grundpostulate bei Kraepelin. Z Klin Psychol Psychopathol Psychother 36:328–336PubMed
20.
Zurück zum Zitat Jablensky A (1999) The nature of psychiatric classification: issues beyond ICD-10 and DSM-IV. Aust N Z J Psychiatry 33:137–144PubMedCrossRef Jablensky A (1999) The nature of psychiatric classification: issues beyond ICD-10 and DSM-IV. Aust N Z J Psychiatry 33:137–144PubMedCrossRef
22.
Zurück zum Zitat Jablensky A (2005) Categories, dimensions and prototypes: critical issues for psychiatric classification. Psychopathology 38:201–205PubMedCrossRef Jablensky A (2005) Categories, dimensions and prototypes: critical issues for psychiatric classification. Psychopathology 38:201–205PubMedCrossRef
23.
Zurück zum Zitat Keefe RSE, Fenton WS (2007) How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull, 33:912–920 Keefe RSE, Fenton WS (2007) How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull, 33:912–920
24.
Zurück zum Zitat Kendler KS (2006) Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 163:1138–1146PubMedCrossRef Kendler KS (2006) Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 163:1138–1146PubMedCrossRef
25.
Zurück zum Zitat Kraepelin E (1920) Die Erscheinungsformen des Irreseins. Z Ges Neurol Psychiatr 62:1–29CrossRef Kraepelin E (1920) Die Erscheinungsformen des Irreseins. Z Ges Neurol Psychiatr 62:1–29CrossRef
26.
Zurück zum Zitat Kupfer DJ, First MB, Regier DA (eds) (2002) A research agenda for DSM-V. American Psychiatric Association, Washington Kupfer DJ, First MB, Regier DA (eds) (2002) A research agenda for DSM-V. American Psychiatric Association, Washington
27.
Zurück zum Zitat Levin T (2006) Schizophrenia should be renamed to help educate patients and the public. Int J Soc Psychiatry 52:324–331PubMedCrossRef Levin T (2006) Schizophrenia should be renamed to help educate patients and the public. Int J Soc Psychiatry 52:324–331PubMedCrossRef
28.
Zurück zum Zitat McGorry PD (2007) Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 164:859–860PubMedCrossRef McGorry PD (2007) Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 164:859–860PubMedCrossRef
29.
Zurück zum Zitat Murphy D, Stich S (2000) Darwin in the madhouse: evolutionary psychology and the classification of mental disorders. In: Carruthers P, Chamberlain A (eds) Evolution and the human mind. Cambridge University Press, Cambridge, pp 62–92 Murphy D, Stich S (2000) Darwin in the madhouse: evolutionary psychology and the classification of mental disorders. In: Carruthers P, Chamberlain A (eds) Evolution and the human mind. Cambridge University Press, Cambridge, pp 62–92
30.
Zurück zum Zitat Owen MJ, Craddock N, Jablensky A (2007) The genetic deconstruction of psychosis. Schizophr Bull, 33:905–911 Owen MJ, Craddock N, Jablensky A (2007) The genetic deconstruction of psychosis. Schizophr Bull, 33:905–911
31.
Zurück zum Zitat Peralta V, Cuesta MJ (2003) The diagnosis of schizophrenia: Old wine in new bottles. Int J Psychol Psychol Ther 3:141–152 Peralta V, Cuesta MJ (2003) The diagnosis of schizophrenia: Old wine in new bottles. Int J Psychol Psychol Ther 3:141–152
32.
Zurück zum Zitat Phillips ML, Vieta E (2007) Identifying functional neuroimaging biomarkers of bipolar disorders: toward DSM-V. Schizophr Bull, 33:893–904 Phillips ML, Vieta E (2007) Identifying functional neuroimaging biomarkers of bipolar disorders: toward DSM-V. Schizophr Bull, 33:893–904
33.
Zurück zum Zitat Regier DA (2007) Time for a fresh start? Rethinking psychosis in DSM-V. Schizophr Bull, 33:843–845 Regier DA (2007) Time for a fresh start? Rethinking psychosis in DSM-V. Schizophr Bull, 33:843–845
34.
Zurück zum Zitat Regier DA, Sirovatka P, Rubio-Stipec M, Narrow WE (2007) The future of psychiatric diagnosis: the APA/WHO/NIH research planning process for DSM and ICD. Die Psychiatrie 4:98–104 Regier DA, Sirovatka P, Rubio-Stipec M, Narrow WE (2007) The future of psychiatric diagnosis: the APA/WHO/NIH research planning process for DSM and ICD. Die Psychiatrie 4:98–104
35.
Zurück zum Zitat Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52:139–153PubMedCrossRef Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52:139–153PubMedCrossRef
36.
Zurück zum Zitat Saraceno B, Saxena S (2007) Issues around work on the classification of mental and behavioural disorders in world health organization. Die Psychiatrie 4:86–91 Saraceno B, Saxena S (2007) Issues around work on the classification of mental and behavioural disorders in world health organization. Die Psychiatrie 4:86–91
37.
Zurück zum Zitat Sartorius N (2007) Zukunftsperspektiven der Klassifikation psychischer Störungen. Die Psychiatrie 4:75–76 Sartorius N (2007) Zukunftsperspektiven der Klassifikation psychischer Störungen. Die Psychiatrie 4:75–76
38.
Zurück zum Zitat Sato M (2006) Renaming schizophrenia: a Japanese perspective. World Psychiatry 5:53–55PubMed Sato M (2006) Renaming schizophrenia: a Japanese perspective. World Psychiatry 5:53–55PubMed
39.
Zurück zum Zitat Schneider K (1959) Clinical pathology. Translated by Hamilton MW. Grune & Stratton, New York Schneider K (1959) Clinical pathology. Translated by Hamilton MW. Grune & Stratton, New York
40.
Zurück zum Zitat Thaker GK (2007) Endophenotypic studies in schizophrenia: promise and challenges. Schizophr Bull 33:1–2PubMedCrossRef Thaker GK (2007) Endophenotypic studies in schizophrenia: promise and challenges. Schizophr Bull 33:1–2PubMedCrossRef
41.
Zurück zum Zitat Tsuang MT, Stone WS, Faraone SV (2000) Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry 157:1041–1050PubMedCrossRef Tsuang MT, Stone WS, Faraone SV (2000) Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry 157:1041–1050PubMedCrossRef
42.
Zurück zum Zitat Üstün TB, Jakob R (2007) The development of the 11th revision of the ICD: trends and challenges. Die Psychiatrie 4:77–85 Üstün TB, Jakob R (2007) The development of the 11th revision of the ICD: trends and challenges. Die Psychiatrie 4:77–85
43.
Zurück zum Zitat Wölwer W, Frommann N, Halfmann S, Piaszek A, Streit M, Gaebel W (2005) Remediations of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program. Schizophr Res 80:295–303PubMedCrossRef Wölwer W, Frommann N, Halfmann S, Piaszek A, Streit M, Gaebel W (2005) Remediations of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program. Schizophr Res 80:295–303PubMedCrossRef
44.
Zurück zum Zitat Zacher P, Kandler KS (2007) Psychiatric disorders: a conceptual taxonomy. Am J Psychiatry 164:557–565CrossRef Zacher P, Kandler KS (2007) Psychiatric disorders: a conceptual taxonomy. Am J Psychiatry 164:557–565CrossRef
Metadaten
Titel
The DSM-V initiative “deconstructing psychosis” in the context of Kraepelin’s concept on nosology
verfasst von
Univ.-Prof. Dr. med. Wolfgang Gaebel
Priv.-Doz. Dr. med. Jürgen Zielasek
Publikationsdatum
01.06.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe Sonderheft 2/2008
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-008-2009-y

Weitere Artikel der Sonderheft 2/2008

European Archives of Psychiatry and Clinical Neuroscience 2/2008 Zur Ausgabe

STUDY BASED DISCUSSION

Evidence for separate diseases?

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.